SCHEMBL18154592

SCHEMBL18154592

C=Cc1cc2ccc(N(C)C)cc2oc1=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC16A3 O15427 3/20 0.57
▸ MEN1 O00255 4/20 0.55
▸ MAPT P10636 4/20 0.55
▸ KMT2A Q03164 4/20 0.55
▸ KDM4E B2RXH2 3/20 0.55
▸ ALDH1A1 P00352 3/20 0.55
▸ HPGD P15428 3/20 0.55
▸ NPSR1 Q6W5P4 1/20 0.55
▸ CYP19A1 P11511 1/20 0.46
▸ PGR P06401 4/20 0.42
▸ USP2 O75604 2/20 0.42
▸ APAF1 O14727 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ ATM Q13315 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ SLC16A1 P53985 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ MAOB P27338 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30498712 0.86 MEN1 (0.72) SLC16A3MEN1MAPTKMT2AKDM4E
SCHEMBL11583789 0.86 MEN1 (0.72) SLC16A3MEN1MAPTKMT2AKDM4E
SCHEMBL12893272 0.84 MEN1 (0.78) SLC16A3MEN1MAPTKMT2AKDM4E
SCHEMBL17768955 0.80 SLC16A3 (0.61) SLC16A3MEN1MAPTKMT2AKDM4E
SCHEMBL29423659 0.78 KDM4E (0.57) SLC16A3MEN1MAPTKMT2AKDM4E
SCHEMBL25842366 0.78 SLC16A3 (0.63) SLC16A3MEN1MAPTKMT2AKDM4E
SCHEMBL26009207 0.78 APP (0.56) SLC16A3PGRUSP2APAF1RAB9A
SCHEMBL30878098 0.75 SLC16A3 (0.64) SLC16A3MEN1MAPTKMT2AKDM4E
SCHEMBL17145062 0.74 MEN1 (0.71) SLC16A3MEN1MAPTKMT2AKDM4E
SCHEMBL2030497 0.74 SLC16A3 (0.81) SLC16A3MEN1MAPTKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3283461-B1 NOVEL COUMARIN DERIVATIVE FOR DETECTION OF CYSTEINE AND PROCESS FOR THE SYNTHESIS THEREOF COUNCIL SCIENT IND RES (IN) 2022-03-30 — — EP disclosed
US-10030002-B2 Coumarin derivative for detection of cysteine and process for the synthesis thereof COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2018-07-24 — — US disclosed
US-20180093963-A1 NOVEL COUMARIN DERIVATIVE FOR DETECTION OF CYSTEINE AND PROCESS FOR THE SYNTHESIS THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2018-04-05 — — US disclosed
EP-3283461-A1 NOVEL COUMARIN DERIVATIVE FOR DETECTION OF CYSTEINE AND PROCESS FOR THE SYNTHESIS THEREOF Council of Scientific and Industrial Research (IN) 2018-02-21 — — EP disclosed
WO-2016166773-A1 NOVEL COUMARIN DERIVATIVE FOR DETECTION OF CYSTEINE AND PROCESS FOR THE SYNTHESIS THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-10-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180093963-A1 NOVEL COUMARIN DERIVATIVE FOR DETECTION OF CYSTEINE AND PROCESS FOR THE SYNTHESIS THEREOF ALDH7A1, LANCL1, CPB1 SLC16A3 2914/4885MEN1 4540/4885MAPT 4795/4885
US-10030002-B2 Coumarin derivative for detection of cysteine and process for the synthesis thereof ALDH7A1, LANCL1, CPA1 SLC16A3 2758/4885MEN1 4608/4885MAPT 4707/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback